STOCK TITAN

If You Invested in Galderma Group Ag (GDERF)

Healthcare · Drug Manufacturers - Specialty & Generic · OTC Link
Looking for the current price? See the GDERF quote & overview
$1,000 invested 1 Year Ago
$1,291
+29.1% total 29.4% CAGR
Bought on Jul 24, 2025 at $162.10
$1,000 invested 5 Years Ago
N/A
Trading since 2024-05-03

What $1,000 or $10,000 in GDERF Would Be Worth Today

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since May 3, 2024
$1,000 $1,291 +29% $2,734 +173%
$10,000 $12,909 +29% $27,336 +173%

Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for GDERF

$1,000 Investment Over Time

GDERF vs S&P 500

Year-by-Year Returns

GDERF annual performance
Year Start Price End Price Annual Return Cumulative
2024 $76.55 $97.00 +26.7% +26.7%
2025 $108.65 $205.25 +88.9% +168.1%
2026 $201.00 $209.25 +4.1% +173.4%

About Galderma Group Ag

Healthcare · OTC Link

GALDERMA GROUP AG (GDERF) is a healthcare company focused on dermatology. According to company information, Galderma describes itself as a pure-play dermatology category leader with a presence in approximately 90 countries. The company concentrates on the human skin and offers a science-based portfolio of brands and services across several dermatology segments.

Galderma states that its activities span the full spectrum of the fast-growing dermatology market through three main areas: Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. These areas reflect a mix of prescription treatments, aesthetic procedures and consumer-focused skincare products, all centered on skin health and appearance. The company emphasizes that it works in partnership with healthcare professionals to meet individual consumer and patient needs.

Founded in 1981, Galderma notes that it has consistently dedicated its focus and passion to the skin as the body’s largest organ. Its stated goal is to advance dermatology "for every skin story," highlighting an emphasis on both medical and emotional aspects of skin conditions. The company’s dermatology portfolio includes premium flagship brands, one of which is Differin, an acne care line that is part of Galderma’s dermatological skincare offering.

Dermatological Skincare and Differin

Within dermatological skincare, Galderma highlights Differin as a key acne care brand. Differin is described as having been the first brand to receive FDA approval to make the power of a prescription-strength, acne-fighting retinoid available over the counter in the United States, introducing a new ingredient to the OTC acne category after more than three decades. The Differin portfolio is said to include cleansers, treatments and moisturizers that support acne management and broader skincare routines.

Galderma positions Differin as a brand that addresses both the physical and emotional impact of acne. Company materials reference the significant number of people affected by acne and the effect it can have on self-confidence, particularly among teens and young adults. In this context, Differin is presented as part of Galderma’s broader effort to provide effective acne solutions and to support users in managing skin health in everyday life.

Engagement with Digital and Gaming Communities

Galderma’s communications also describe how the company, through Differin, engages with digital platforms and gaming communities. The Differin "Level Up" campaign is integrated into several popular Roblox experiences. This campaign is designed to combine mini games with acne care education, aiming to reach teen and young adult gamers where they already spend time online.

In this Roblox activation, Differin uses interactive mini games that reference specific Differin products, such as a 10% benzoyl peroxide maximum strength foaming cleanser and a 10% benzoyl peroxide spot treatment. Players can participate in activities that symbolically clean or treat acne within the game environment. The campaign is described as blending education with commerce by allowing participants to upload receipts from Differin product purchases at retailers where Differin is sold in order to unlock in-game rewards.

Beyond Roblox, Galderma notes that the Differin "Level Up" campaign extends across the broader gaming ecosystem, including platforms and services such as Twitch, Reddit, TikTok and YouTube. The stated objective is to reach Gen Z and Gen Alpha audiences with information and solutions for managing acne, while also acknowledging the role that gaming communities play in social interaction, creativity and confidence building.

Focus on Science-Based Dermatology

Across its portfolio, Galderma emphasizes an innovative, science-based approach to dermatology. The company states that it delivers premium brands and services grounded in scientific research and clinical understanding of skin conditions. Its three core areas—Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology—reflect a combination of medical treatments and consumer products that are intended to address both functional and aesthetic skin concerns.

Galderma also highlights its collaboration with healthcare professionals as a central part of its model. By working with dermatologists and other specialists, the company aims to align its products and services with clinical practice and patient needs. This partnership-based approach is presented as a way to achieve superior outcomes for both consumers and patients.

Global Presence and Market Positioning

According to company statements, Galderma is present in approximately 90 countries. This global footprint supports the distribution of its dermatology brands and services across diverse markets. While specific regional breakdowns are not provided in the available information, the broad international presence underscores the scale of its dermatology focus.

Galderma characterizes itself as a pure-play dermatology company, meaning its activities are concentrated on skin health rather than spanning multiple unrelated healthcare areas. This specialization is central to how the company presents its identity and strategy. By focusing on dermatology, Galderma positions its portfolio to address a wide range of skin conditions and aesthetic needs, from acne care to injectable treatments and therapeutic solutions.

Role of Acne Care within Galderma

Within Galderma’s broader dermatology offering, acne care is highlighted as a significant area, particularly through the Differin brand. Company materials cite data from external organizations about the prevalence of acne and its psychological impact, especially among younger age groups. In response, Galderma frames Differin as both a treatment option and a means of supporting confidence and mental well-being related to skin appearance.

The Differin "Level Up" campaign on Roblox and other platforms illustrates how Galderma connects its dermatological expertise with contemporary digital behavior. By situating acne education and product awareness in gaming environments, the company aims to reach users in a context that feels natural and engaging to them. This approach also reflects Galderma’s interest in combining educational content with interactive experiences.

Partnerships and Educational Emphasis

Galderma’s communications stress education as a recurring theme. In the Differin campaign, the company focuses on acne care education, product knowledge and confidence building. The Roblox mini games, for example, are described as teaching players about acne-fighting products while they play. This reflects a broader pattern in Galderma’s positioning, where information and awareness are integrated into how its brands interact with consumers.

Overall, GALDERMA GROUP AG presents itself as a dermatology-focused healthcare company with a science-based portfolio, a global presence and a strong emphasis on skin health education. Its activities range from injectable aesthetics and therapeutic treatments to consumer skincare brands like Differin, which are used to address common conditions such as acne and to support both physical and emotional aspects of skin well-being.

Market Cap
$42.9B
Current Price
$209.25
View full GDERF overview

Frequently Asked Questions

Galderma Group Ag investment returns

How much would $1,000 invested in Galderma Group Ag be worth today?

If you invested $1,000 in Galderma Group Ag (GDERF) 1 years ago on 2025-07-24, your investment would be worth $1,291 today, representing a +29.1% total return, growing at a compounded rate of 29.4% per year (CAGR).

Has Galderma Group Ag outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare GDERF performance over available time periods.

What is Galderma Group Ag's average annual return?

The compound annual growth rate (CAGR) of GDERF over the past 1 years is 29.4%, growing at a compounded rate each year. Individual years vary significantly — GDERF's best recent year was 2025 (+88.9%) and worst was 2026 (+4.1%).

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.